by John Conrad | Mar 19, 2020 | COVID, COVIDFDA
In response to growing difficulties companies are expecting to face running trials, the Food and Drug Administration has issued a new guidance to help navigate the problems. Considerations for ongoing trials: Ensuring the safety of trial participants is paramount....
